In their announcement about the retatrutide study, Eli Lilly medical experts said that about 11% of study volunteers who received the highest dose of the drug stopped taking it and dropped out of the study due to unpleasant side effects
10.1016/S0304-3940(01)01613-5 41
While BPC-157 isn't a muscle-building peptide, its tissue repair properties may support the musculoskeletal system during the metabolic stress of caloric restriction and rapid weight change
[DOI] [PubMed] [Google Scholar] 101.Freriksen J.J.M., van Seyen M., Judd A., Gibb D.M., Collins I.J., Greupink R., Russel F.G.M., Drenth J.P.H., Colbers A., Burger D.M
Development and optimization of phytosome for enhancement of therapeutic potential of epiyangambin in Tinospora cordifolia extract identified by GCMS and Docking analysis